Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting

  • Said D
  • Elalfy M
  • Gatzioufas Z
 et al. 
  • 61

    Readers

    Mendeley users who have this article in their library.
  • 60

    Citations

    Citations of this article.

Abstract

Purpose To investigate the efficacy and safety of corneal collagen cross-linking (CXL) with photoactivated riboflavin (photoactivated chromophore for infectious keratitis [PACK]-CXL) in the management of infectious keratitis with corneal melting. Design Prospective clinical trial. Participants Forty eyes from 40 patients with advanced infectious keratitis and coexisting corneal melting. Methods Twenty-one patients (21 eyes) underwent PACK-CXL treatment in addition to antimicrobial therapy. The control group consisted of 19 patients (19 eyes) who received only antimicrobial therapy. Main Outcome Measures The slit-lamp characteristics of the corneal ulceration, corrected distance visual acuity, duration until healing, and complications were documented in each group. The Mann-Whitney U test was used for statistical analysis. P values less than 0.05 were considered statistically significant. Results The average time until healing was 39.76±18.22 days in the PACK-CXL group and 46.05±27.44 days in the control group (P = 0.68). After treatment and healing, corrected distance visual acuity was 1.64±0.62 in the PACK-CXL group and 1.67±0.48 in the control group (P = 0.68). The corneal ulceration's width and length was significantly bigger in the PACK-CXL group (P = 0.004 and P = 0.007). Three patients in the control group demonstrated corneal perforation; infection recurred in 1 of them. No serious complications occurred in the PACK-CXL group. Conclusions Corneal CXL with photoactivated riboflavin did not shorten the time to corneal healing; however, the complication rate was 21% in the control group, whereas there was no incidence of corneal perforation or recurrence of the infection in the PACK-CXL group. These results indicate that PACK-CXL may be an effective adjuvant therapy in the management of severe infectious keratitis associated with corneal melting.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Dalia G. Said

  • Mohamed S. Elalfy

  • Zisis Gatzioufas

  • Ehab S. El-Zakzouk

  • Mansour A. Hassan

  • Mohamed Y. Saif

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free